This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) shed 0.93% to $630.59 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.18% to 4,513.04 and Dow Jones Industrial Average falling 1.34% to 34,022.04. This was the stock's second consecutive day of losses. Regeneron Pharmaceuticals Inc. closed $56.03 below its 52-week high ($686.62), which the company achieved on September 3rd.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 1.38% to $158.08, Novartis AG ADR (NOVN.EB) rose 0.15% to $79.82, and Amgen Inc. (AMGN) rose 0.97% to $200.80. Trading volume (731,637) remained 47,671 below its 50-day average volume of 779,308.
Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2021.
(END) Dow Jones Newswires
December 01, 2021 17:19 ET (22:19 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.